A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Vericel Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,079,048 shares of VCEL stock, worth $63.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,079,048
Previous 1,031,940 4.56%
Holding current value
$63.2 Million
Previous $47.3 Million 3.71%
% of portfolio
0.11%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.25 - $53.56 $1.99 Million - $2.52 Million
47,108 Added 4.56%
1,079,048 $45.6 Million
Q2 2024

Jul 29, 2024

BUY
$41.71 - $52.9 $427,318 - $541,960
10,245 Added 1.0%
1,031,940 $47.3 Million
Q1 2024

May 08, 2024

BUY
$32.52 - $52.33 $3.28 Million - $5.27 Million
100,797 Added 10.95%
1,021,695 $53.1 Million
Q4 2023

Feb 09, 2024

SELL
$30.85 - $37.09 $71,479 - $85,937
-2,317 Reduced 0.25%
920,898 $32.8 Million
Q3 2023

Nov 13, 2023

SELL
$31.69 - $39.25 $3.28 Million - $4.06 Million
-103,562 Reduced 10.09%
923,215 $30.9 Million
Q2 2023

Aug 08, 2023

SELL
$29.0 - $38.37 $4.22 Million - $5.59 Million
-145,629 Reduced 12.42%
1,026,777 $38.6 Million
Q1 2023

May 08, 2023

SELL
$23.85 - $31.34 $46,412 - $60,987
-1,946 Reduced 0.17%
1,172,406 $34.4 Million
Q4 2022

Feb 09, 2023

BUY
$17.65 - $27.37 $1.58 Million - $2.45 Million
89,449 Added 8.24%
1,174,352 $30.9 Million
Q3 2022

Nov 10, 2022

BUY
$22.62 - $32.54 $7.34 Million - $10.6 Million
324,328 Added 42.64%
1,084,903 $25.2 Million
Q2 2022

Aug 04, 2022

BUY
$22.88 - $39.45 $1.78 Million - $3.06 Million
77,583 Added 11.36%
760,575 $19.2 Million
Q1 2022

May 12, 2022

BUY
$31.69 - $43.29 $2.04 Million - $2.79 Million
64,505 Added 10.43%
682,992 $26.1 Million
Q4 2021

Feb 09, 2022

BUY
$35.2 - $52.6 $6.05 Million - $9.05 Million
171,995 Added 38.52%
618,487 $24.3 Million
Q3 2021

Nov 08, 2021

BUY
$46.35 - $59.75 $5.79 Million - $7.46 Million
124,912 Added 38.84%
446,492 $21.8 Million
Q2 2021

Aug 05, 2021

SELL
$47.2 - $67.81 $6.17 Million - $8.87 Million
-130,791 Reduced 28.91%
321,580 $16.9 Million
Q1 2021

May 05, 2021

SELL
$30.93 - $59.48 $16.8 Million - $32.4 Million
-544,170 Reduced 54.61%
452,371 $25.1 Million
Q4 2020

Feb 12, 2021

BUY
$18.53 - $31.5 $18.5 Million - $31.4 Million
996,541 New
996,541 $30.8 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.